Track Noile-Immune Biotech's current assets ($3.6B) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Noile-Immune Biotech (4893.T) currently reports a current assets of $3.6B as of June 2026. That compares with $4.4B in the prior-year period — down 16.5% year over year. Use the charts on this page to explore Noile-Immune Biotech's current assets history and peer comparisons.
Noile-Immune Biotech's current assets decreased from $4.4B to $3.6B — a 16.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Noile-Immune Biotech reported $3.6B in current assets as of June 2026. That compares with $4.4B in the prior-year period — down 16.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current assets of $3.6B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Noile-Immune Biotech, and consider following 4893.T for alerts when major investors trade the stock.
Noile-Immune Biotech is classified in the Healthcare sector. On current assets, it currently shows $3.6B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 4893.T with unrelated industries.